CONTACT INFORMATION
Mark Montondon
Voice 713-589-6879 Fax 713-863-8308
mmontondon@sightlinehealth.com
SightLine Health Welcomes Vonda Wall to Executive Staff
Accomplished professional brings more than 17 years of leadership experience in outpatient procedural and diagnostic services in a multiple facility healthcare system.
HOUSTON, July 1, 2009—SightLine Health, one of the few health care companies in the nation to provide innovative cancer treatments such as Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT) and High Dose Rate (HDR) Brachytherapy, as well as FDA-approved MR-guided focused ultrasound ablation (MRgFUS) for uterine fibroids, recently announced that Vonda Wall has joined their executive staff as Vice President of Operations. Prior to joining the executive team, Vonda ran the operations at SightLine’s Texas Medical Center facility.
Vonda brings to her executive position the proven ability to develop and grow successful outpatient clinics. Prior to joining SightLine, she spent 15 years with the Memorial Hermann Healthcare System. There, she was instrumental in overall strategic planning; program and facility planning; budgeting; developing physician relationships; marketing and revenue enhancement; developing policies, procedures and standards of care; generating programmatic support through partnerships with research-based institutions; and establishing programs for ongoing employee development.
In her new position with SightLine, Vonda will be responsible for the daily oversight of SightLine facilities across the country and will also participate as part of the executive team that investigates and develops new and innovative service lines. “I have worked for many years with one of the most well-respected healthcare systems in the country,” she says, “but working for SightLine Health has been extremely rewarding. The company’s pioneer spirit and keen eye on the healthcare market allows them to bring new and exciting technologies to both patients and physicians quickly and effectively.”
T.J. Farnsworth, SightLine Health’s CEO and president, said that adding Wall to the company’s executive team will have a major effect on their ability to identify cutting-edge therapies and bring them to markets around the country. “We are lucky to have her and she will be a real asset to us going forward.”
About SightLine Health: SightLine Health, headquartered in Houston, Texas, specializes in groundbreaking procedures such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT) and High Dose Rate (HDR) brachytherapy for cancer, as well as the MR-guided focused ultrasound ablation (MRgFUS) procedure, which has been approved by the FDA for uterine fibroids and is in FDA trials for treating other conditions. The company began operations in 2005 when it opened its first facility near the renowned Texas Medical Center. For more information on IMRT, IGRT, HDR Brachytherapy, MRgFUS or SightLine Health, please contact Mark Mondonton, Vice President of Corporate Strategy, at 713-589-6879 or mmontondon@sightlinehealth.com.
